Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Wino115on Jul 19, 2022 3:15pm
90 Views
Post# 34835256

RE:RE:RE:Sitting in the waiting room at Gettysburg

RE:RE:RE:Sitting in the waiting room at Gettysburg

Good luck to her. I also recall a bearded Dr who was in the pictures with Patient #1 along with Dr Shah.   I would guess others will be familiar with some of their trials too.


SPCEO1 wrote: Didn't see him. He said he was thinking of 2 possible drugs for her but didn't identify either.

qwerty22 wrote:

You know what Dr Shah looks like? Corner him, he seems like a guy that might gush. Drop an innocent question like I saw your comment about a particular drug trial recently, what your thoughts on that drug.

 

SPCEO1 wrote:
I have a relative with stage 2 ovarian cancer and my wife and I drove her out to Gettysburg Cancer Center (now renamed) today to possibly begin treatment here. I don't think she will be eligible for TH-1902 though. But this is the site where all the responders so far have been. I see nothing here that indicates anything about TH-1902. It is a pretty unimpressive looking operation (nothing bad, just very plain). But I can confirm it exists!

 

 





<< Previous
Bullboard Posts
Next >>